Status:

UNKNOWN

A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy

Lead Sponsor:

Southwest Hospital, China

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The study, entitled "RCT study of laparoscopic middle hepatic venous guidance versus conventional ananatomical hemihepatectomy", was designed to compare the efficacy of two different ananatomical hemi...

Detailed Description

Backgroud \& Aim:Hepatectomy is the main way to treat all kinds of liver surgical diseases, which can be divided into anatomic hepatectomy and non-anatomic hepatectomy.Among them, anatomic hepatectomy...

Eligibility Criteria

Inclusion

  • the site was limited to the patients who were suitable for dissecting hemihepatectomy;
  • the type of disease was limited to hepatocellular carcinoma;
  • the patients were generally able to tolerate anesthesia, the liver reserve function was good, and the patients were suitable for laparoscopic surgery;
  • child-pugh grade A, no severe liver cirrhosis, portal hypertension, no extrahepatic and extrahepatic metastasis and main vascular invasion;
  • the subjects who participated in this study indicated that they were willing to accept the two surgical methods and agreed to be randomly divided into groups during the operation;
  • 18 ≤ age ≤ 70, male or female.

Exclusion

  • preoperative liver function Child-pugh grade B or C;
  • patients with poor general condition and could not tolerate pneumoperitoneum or anesthesia;
  • patients with severe liver cirrhosis, portal hypertension and lesions invading liver porta;
  • patients with other treatment methods such as radio frequency ablation in addition to dissecting hepatectomy;
  • repeated abdominal operations resulting in severe abdominal adhesion, unable to perform laparoscopic hepatectomy; male and female are not limited

Key Trial Info

Start Date :

December 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 23 2023

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT04422249

Start Date

December 23 2019

End Date

December 23 2023

Last Update

December 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Southwest Hospital

Chongqing, Chongqing Municipality, China, 400038